Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
Trending on Bing
Votes to accept $2.8B plan
US service members injured
Gets Walk of Fame star
At least 100 killed in landslide
Judge revisits immigration law
Planet that could support life
Signs new abortion bill
Arrested, charged w/ fraud
Holds rally in South Bronx
OH gov. calls special session
Wash. wind farm proposal
Ala. coal ash plan rejected
HPV vaccine benefits for men
Wade launches Translatable
Drops ‘Dark Times' album
Daytime Emmy Awards hosts
Wins Idaho caucuses
WH state dinner for Kenya
X to make 'likes' private
CIA director to visit Europe
Planet parade 2024
Approves ETFs for Ether
To address Congress soon
Warns of salmonella outbreak
Dow falls by over 600 points
Werder leaving ESPN
Evans suffers minor stroke
To launch $5 value meal
Limits state-affiliated media
Sued by cancer victims
Expects a 2024 cash burn
Bill to prevent CBDCs
Industry targeting youth
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Moderna, FDA and RSV vaccine
FDA Delays Decision on Moderna RSV Shot by 3 Weeks
The agency was originally scheduled to announce its call on Sunday. The company said it hadn’t flagged any issues with the drug’s safety, efficacy, or quality.
FDA delays decision on Moderna's RSV shot until the end of May
The FDA needs a few more weeks to decide the fate of Moderna's RSV vaccine, the company announced. A decision is now slated for the end of May, as opposed to May 12.
Moderna Stock Slips as FDA Delays RSV Vaccine Approval
Key Takeaways Moderna said the Food and Drug Administration (FDA) has delayed its approval decision for the respiratory syncytial virus (RSV) vaccine.The biotech reported it was advised by regulators that their review wouldn't be completed until the end of the month,
Yahoo Finance
14d
FDA delays decision on Moderna RSV vaccine
Moderna on Friday said the Food and
Drug
Administration has postponed an approval
decision
on its experimental
vaccine
for
respiratory syncytial virus
due to “administrative constraints ...
13d
FDA delays decision date for Moderna's RSV vaccine
Just days before its initial deadline, U.S. regulators say they need more time to decide whether or not to approve Moderna's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback